Thermo Fisher Scientific Inc..
multinational company providing scientific instrumentation
ImmuPharma Selects Thermo Fisher CDMO for Kapiglucagon
ImmuPharma has named Thermo Fisher Scientific’s Patheon as the drug product CDMO for Kapiglucagon, following the earlier selection of Bachem for API manufacturing, as it pushes the glucagon prodrug toward IND-enabling development for Type 1 diabetes and potential dual-hormone artificial pancreas applications. The company is pursuing a streamlined regulatory path, potentially a 505(b)(2) in the U.S., with plans to file an IND and begin first-in-human studies subject to regulatory confirmation.
Business · 5 sources · Jul 22, 2026Read itThe journal
Open the journal →The conversation starts in the journal — be the first to post.
About Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. is an American life science and clinical research company. It is a global supplier of analytical instruments, clinical development solutions, specialty diagnostics, laboratory, pharmaceutical and biotechnology services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021).
Everything about Thermo Fisher Scientific Inc. →- Country
- United States
- Headquarters
- Waltham
- Inception
- 2006
- Website
- https://www.thermofisher.com/